Blood Pressure Monitoring Devices Market - Databook 2025 to 2034

The global blood pressure monitoring devices market size accounted for USD 3,820 million in 2024 and is predicted to touch around USD 9,820 million by 2034, growing at a CAGR of 9.9% from 2025 to 2034.

Highlights of the Blood Pressure Monitoring Devices Market

• North America dominated the global blood pressure monitoring devices market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By device type, the non-smart/traditional segment holds a dominant presence in the blood pressure monitoring devices market in 2024.
• By device type, the smart segment is expected to grow at the fastest rate in the market during the forecast period.
• By connectivity type, the non-connected segment led the market.
• By connectivity type, the connected segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By end-use, the hospitals hold a dominant presence in the blood pressure monitoring devices market in 2024.
• By end-use, the homecare segment is expected to grow at the fastest rate in the market during the forecast period.

Industry Valuation and Growth Rate Projection

Blood pressure monitoring devices refer to mercury sphygmomanometers. The significant driving causes of the blood pressure monitoring market are the growth in the older population, lifestyle change, and the development of advanced technologies. The need for blood pressure monitoring devices is anticipated to rise in the upcoming years, as they can assist early diagnosis of an individual’s deteriorating health condition. Meanwhile, advanced blood pressure monitoring devices are programmed for personal usage, which assist in monitoring the health status of an individual remotely.

Blood Pressure Monitoring Devices Market: Stats and Figures

• According to the WHO, nearly every 1 in 3 adults is hypertensive, with majorly male incidence higher than females mostly under the 50 years group. Except for the age of 50, the incidence reaches almost 49%, or every 1 out of 2 patients, with almost equal incidence among both men and women.

How AI Has Benefitted the Blood Pressure Monitoring Devices Market

• Blood pressure is an essential indicator for detecting hypertension. Presently, blood pressure measurement techniques are primarily based on electronic sphygmomanometers at home or
• mercury sphygmomanometers in hospitals. Optimal management has frequent blood pressure analyzing and antihypertensive medication titration, but in the conventional office-derived care delivery model, individuals have their blood pressure tackled only intermittently and in such a way that is indicated to misdiagnosis with masked hypertension or white coats.
• AI has the capability to detect risk factors and phenotypes of HTN, forecast the risk of incident HTN, estimate blood pressure (BP), diagnose HTN, develop novel cuffless techniques for BP measurement, and precisely detect factors linked with treatment adherence and success.
• However, AI has even been used to detect information from important randomized controlled trials investing different BP aims to uncover previously understood factors linked with CV results.
• AI-incorporated HTN care has the potency to revolutionize clinical practice by implementing customized prevention and treatment methods, like analyzing optimal and patient-precise BP goals, detecting the most efficient antihypertensive medication regimen for a patient, and generating interventions aimed at modifiable risk factors.

Industry Leader Announcements

• Albert Lim, CEO at Microlife

"We are pleased to announce the successful certification under the EU Medical Device Regulation," said Albert Lim, CEO at Microlife. "This accomplishment reflects our commitment to delivering innovative and high-quality medical devices that meet the most stringent regulatory standards. We are proud to continue our mission of improving healthcare worldwide and expanding our presence in the European market."

• Deepak Chopra, OSI Systems CEO

OSI Systems CEO Deepak Chopra stated, "Spacelabs has long been considered the 'gold standard' equipment provider for ABPM monitoring equipment within the acute care and hospital markets. This new partnership with dabl(R), initially for the United Kingdom and Italy, enables primary healthcare practitioners and local pharmacies the ability to provide fast, reliable and interpretive reports to dramatically help improve patient care and management."

• Dave Hughes, Founder and CEO, Novosound

Novosound founder and CEO Dave Hughes said, “Scotland has long been at the forefront of ultrasound innovation, and we are proud to continue this legacy. Monitoring blood pressure with ultrasound, and without the need for a cuff, marks a significant advancement in how we can address global health and wellness issues.”

Geographical Insights

The blood pressure monitoring devices market is experiencing significant growth, with North America maintaining its position as the dominant region while Europe emerges as the rapidly growing market. In the APAC region, China stands out as a driver of growth in the space.

North America

North America dominated the global market in 2024. The growth is owing to the highly regulated and well-established healthcare infrastructure in the area. The surging support and need for blood pressure monitors that include aneroid gauges to hypertensive individuals are thus boosting the growth.

Europe

Europe is experiencing rapid growth in the blood pressure monitoring devices market during the forecast period. Europe's healthcare focus on preventive care, combined with a rising knowledge of cardiovascular health, boosted the need for accurate and acceptable blood pressure monitoring apparatus. As populations are more aware about health and seek clues to maintain hypertension and linked conditions, the market for this apparatus has stretched substantially.

China and APAC

Asia Pacific (APAC) is projected to be the fastest growing in the market during the forecast period. This expansion is owing to reasons such as accelerated funding by principal companies in advancing economies in the Asia-Pacific. China’s vast population and rising hypertension rates impacting millions of people are driving rapid expansion in the blood pressure monitoring market. As China focuses on tech-driven healthcare, smart monitoring equipment is gaining momentum, mainly in urban zones where digital health acceptance is at its peak.

Recent Developments

• In November 2024, OMRON Healthcare disclosed that the U.S. Food and Drug Administration (FDA) has approved the firm its De Novo authorization to market the latest home blood pressure monitors featuring cutting-edge AI-derived atrial fibrillation detection.
• In September 2024, Roivant obtained from Bayer certain varieties of pulmonary hypertension, a serious lung disorder in which high blood pressure impacts the arteries in the lungs and destroys the heart.

Competitive Landscape

The blood pressure monitoring devices market is witnessing significant growth owing to reasons like the growing incidence of hypertension, the growth in the geriatric population, the rising prevalence of cardiovascular disorder, and technological developments in good offerings.

• Company Name: Briggs Healthcare
• Year of Incorporation: 1947
• Headquarters: West Des Moines, Iowa, USA

Briggs Healthcare requirement from healthcare for ever more efficient therapies and rising competition. Therefore, the field has seen the development of start-up medtech firms that are offering the most innovative and the latest solutions to issues challenged by the healthcare domain.

• Company Name: American Diagnostics Corporation
• Year of Incorporation: 1984
• Headquarters: Hauppauge, New York

American Diagnostic Corporation (ADC) is considered the world’s chief producer of diagnostic medical goods, accessories, and personal equipment for the healthcare domain. For 40 years, it has been designing, producing, and supplying stethoscopes and other core diagnostic goods that offer an unmatched value proposition with a buying experience.

• Company Name: Rossmax International Ltd.
• Year of Incorporation: 1988
• Headquarters: Taipei, Taiwan

Rossmax is a manufacturer of healthcare goods within the medical instrument industry. The company provides a variety of devices for hypertension, blood glucose management, respiratory care, fever management, and numerous other health-related needs. These goods are programmed to aid in the monitoring, prevention, and therapy of numerous health conditions.